[1] CERDA C,PEREZ-AYUSO RM,RIQUELME A,et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome[J]. J Hepatol,2007,47 (3):412-417. [2] GAMBARIN-GELWAN M,KINKHABWALA SV,SCHIANO TD,et al. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome[J]. Clin Gastroenterol Hepatol,2007,5(4):496-501. [3] 郑若,丁彩飞. 多囊卵巢综合征患者非酒精性脂肪性肝病发病情况分析[J]. 中华妇产科杂志,2008,43(2):98-101. [4] THE ROTTERDAM ESHRE/ASRM-SPONSORED PCOS CONSENSUS WORKSHOP GROUP. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS)[J]. Hum Reprod,2004,19:41-47. [5] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南[J]. 实用肝脏病杂志,2007,10(1):4-5 [6] SETJI TL,BROWN AJ. Polycystic ovary syndrome: diagnosis and treatment[J]. Am J Med,2007,120(2):128-132. [7] EHRMANN DA. Polycystic ovary syndrome[J]. N Engl J Med,2005,352(12):1223-1236. [8] SCHWIMMER JB,KHORRAM O,CHIU V,et al. Abnormal aminotransferase activity in women with polycystic ovary syndrome[J]. Fertil Steril,2005,83(2):494-497. [9] CARMINA E. Need for liver evaluation in polycystic ovary syndrome[J]. J Hepatol,2007,47(3):313-315. [10] CRESSWELL J,FRASER R,BRUCE C,et al. Relationship between polycystic ovaries,body mass index and insulin resistance[J]. Acta Obstet Gynecol Scand,2003,82:61-64. |